Amos M. Yinnon

4.4k total citations
125 papers, 3.0k citations indexed

About

Amos M. Yinnon is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Amos M. Yinnon has authored 125 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 30 papers in Infectious Diseases and 25 papers in Surgery. Recurrent topics in Amos M. Yinnon's work include Urinary Tract Infections Management (19 papers), Bacterial Identification and Susceptibility Testing (19 papers) and Antibiotic Resistance in Bacteria (17 papers). Amos M. Yinnon is often cited by papers focused on Urinary Tract Infections Management (19 papers), Bacterial Identification and Susceptibility Testing (19 papers) and Antibiotic Resistance in Bacteria (17 papers). Amos M. Yinnon collaborates with scholars based in Israel, United States and United Kingdom. Amos M. Yinnon's co-authors include Bernard Rudensky, David Raveh, Yechiel Schlesinger, Yonit Wiener‐Well, Marc V. Assous, Tamar Lachish, Shmuel Benenson, Nathan P. Gottehrer, John J. Treanor and Tali Bdolah‐Abram and has published in prestigious journals such as Annals of Internal Medicine, Cancer and Clinical Infectious Diseases.

In The Last Decade

Amos M. Yinnon

121 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amos M. Yinnon Israel 31 1.2k 827 604 535 463 125 3.0k
Jonas Marschall Switzerland 30 973 0.8× 807 1.0× 567 0.9× 361 0.7× 620 1.3× 146 3.3k
Bernard Rudensky Israel 30 1.1k 0.9× 814 1.0× 388 0.6× 573 1.1× 622 1.3× 131 4.0k
Evelina Tacconelli Italy 33 1.3k 1.1× 1.2k 1.5× 591 1.0× 401 0.7× 300 0.6× 117 3.4k
Markos Marangos Greece 30 958 0.8× 942 1.1× 675 1.1× 308 0.6× 386 0.8× 180 2.9k
Carol Chenoweth United States 30 943 0.8× 1.1k 1.3× 269 0.4× 416 0.8× 405 0.9× 72 3.0k
Lennox K. Archibald United States 37 1.1k 0.9× 1.4k 1.7× 568 0.9× 621 1.2× 596 1.3× 87 4.3k
Emine Alp Türkiye 30 1.1k 0.9× 682 0.8× 815 1.3× 241 0.5× 281 0.6× 145 3.1k
Jihad Bishara Israel 33 1.8k 1.5× 1.7k 2.0× 556 0.9× 492 0.9× 408 0.9× 131 3.6k
Susan Whittier United States 41 1.5k 1.3× 1.9k 2.2× 973 1.6× 408 0.8× 391 0.8× 118 4.7k
Silvano Esposito Italy 31 681 0.6× 1.2k 1.4× 430 0.7× 563 1.1× 464 1.0× 147 3.4k

Countries citing papers authored by Amos M. Yinnon

Since Specialization
Citations

This map shows the geographic impact of Amos M. Yinnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos M. Yinnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos M. Yinnon more than expected).

Fields of papers citing papers by Amos M. Yinnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amos M. Yinnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos M. Yinnon. The network helps show where Amos M. Yinnon may publish in the future.

Co-authorship network of co-authors of Amos M. Yinnon

This figure shows the co-authorship network connecting the top 25 collaborators of Amos M. Yinnon. A scholar is included among the top collaborators of Amos M. Yinnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amos M. Yinnon. Amos M. Yinnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Najjar‐Debbiny, Ronza, Bibiana Chazan, M. Todd Greene, et al.. (2022). Healthcare-associated infection prevention and control practices in Israel: results of a national survey. BMC Infectious Diseases. 22(1). 739–739. 4 indexed citations
2.
Mendlovic, Joseph, Todd Zalut, Gabriel Munter, et al.. (2021). Mixed effect of increasing outflow of medical patients from an emergency department. Israel Journal of Health Policy Research. 10(1). 59–59. 3 indexed citations
3.
Friedmann, Reuven, et al.. (2018). [AN EDUCATIONAL INTERVENTION TO REDUCE THE RATE OF CONTAMINANTS IN BLOOD CULTURES AND IMPROVE APPROPRIATE ANTIBIOTIC TREATMENT].. PubMed. 157(2). 72–76.
4.
Friedmann, Reuven, et al.. (2017). Can Procalcitonin Contribute to the Diagnosis of Clostridium difficile Colitis?. PubMed. 19(5). 313–316. 5 indexed citations
5.
Assous, Marc V., et al.. (2017). Spondylodiskitis and endocarditis due to Streptococcus gordonii. Annals of Clinical Microbiology and Antimicrobials. 16(1). 68–68. 20 indexed citations
6.
Friedmann, Reuven, et al.. (2016). Operating a Monitoring Unit in the Geriatric Department: Effects on Outcomes. Journal of the American Geriatrics Society. 65(2). 427–432. 1 indexed citations
7.
Wiener‐Well, Yonit, et al.. (2015). Mortality due toblaKPCKlebsiella pneumoniaebacteraemia. Journal of Antimicrobial Chemotherapy. 71(4). 1083–1087. 52 indexed citations
8.
Никитин, И. Г., et al.. (2009). Diagnostic Value of Chest Radiographs in Bedridden Patients Suspected of Having Pneumonia. The American Journal of Medicine. 123(1). 88.e1–88.e5. 108 indexed citations
9.
Wiener‐Well, Yonit, David Raveh, Yechiel Schlesinger, Amos M. Yinnon, & Bernard Rudensky. (2009). Cefuroxime for Empiric Treatment of Community-Acquired Pneumococcal Pneumonia: Is There a Generation Gap?. Chemotherapy. 55(2). 97–104. 1 indexed citations
10.
11.
Shitrit, Ariella Bar‐Gil, Bernard Rudensky, Amos M. Yinnon, et al.. (2003). A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumonia. Blood Coagulation & Fibrinolysis. 14(8). 745–748. 35 indexed citations
12.
Fefer, Paul, et al.. (2002). Changing Epidemiology of Infective Endocarditis: A Retrospective Survey of 108 Cases, 1990-1999. European Journal of Clinical Microbiology & Infectious Diseases. 21(6). 432–437. 42 indexed citations
13.
Rudensky, Bernard, et al.. (2002). Anaerobiospirillum succiniciproducens bacteremia in a young child. The Pediatric Infectious Disease Journal. 21(6). 575–576. 11 indexed citations
14.
Raveh, David, et al.. (2002). Bacteremia due to beta-hemolytic streptococcus group g: increasing incidence and clinical characteristics of patients. The American Journal of Medicine. 112(8). 622–626. 96 indexed citations
15.
Yinnon, Amos M.. (2001). Whither Infectious Diseases Consultations? Analysis of 14,005 Consultations from a 5‐Year Period. Clinical Infectious Diseases. 33(10). 1661–1667. 54 indexed citations
16.
Solomon, Michael J., David Raveh, Yechiel Schlesinger, & Amos M. Yinnon. (2000). Assessment of knowledge of guidelines for the prevention of infective endocarditis amongst clinicians in a teaching hospital. Journal of Hospital Infection. 45(4). 311–317. 9 indexed citations
17.
Yinnon, Amos M., et al.. (2000). Cefuroxime utilization evaluation: impact of physician education on prescribing patterns.. PubMed. 2(3). 187–91. 8 indexed citations
18.
Levin, Phillip D., Moshe Hersch, Bernard Rudensky, & Amos M. Yinnon. (2000). The use of the arterial line as a source for blood cultures. Intensive Care Medicine. 26(9). 1350–1354. 9 indexed citations
19.
Yinnon, Amos M., et al.. (1993). Cryptococcal Peritonitis: Report of a Case Developing During Continuous Ambulatory Peritoneal Dialysis and Review of the Literature. Clinical Infectious Diseases. 17(4). 736–741. 28 indexed citations
20.
Yinnon, Amos M., et al.. (1992). A Practical Intervention Programme Aimed at Decreasing High Serum Cholesterol Levels in Primary Care. Family Practice. 9(2). 167–170. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonas Marschall Breakdown of academic impact, for papers by Bernard Rudensky Breakdown of academic impact, for papers by Evelina Tacconelli Breakdown of academic impact, for papers by Markos Marangos Breakdown of academic impact, for papers by Carol Chenoweth Breakdown of academic impact, for papers by Lennox K. Archibald Breakdown of academic impact, for papers by Emine Alp Breakdown of academic impact, for papers by Jihad Bishara Breakdown of academic impact, for papers by Susan Whittier Breakdown of academic impact, for papers by Silvano Esposito
Rankless by CCL
2026